Treating and Preventing Levodopa-Induced Dyskinesias
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 14 (5) , 337-345
- https://doi.org/10.2165/00002512-199914050-00002
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patientsActa Neurologica Scandinavica, 1996
- “Off” painful dystonia in Parkinson's disease treated with botulinum toxinMovement Disorders, 1995
- Comparative study of selegiline plus L‐dopa–carbidopa versus L‐dopa–carbidopa alone in the treatment of parkinson's diseaseAnnals of Neurology, 1995
- Suppression of dyskinesias in advanced Parkinson's disease: Moderate daily clozapine doses provide long‐term dyskinesia reductionMovement Disorders, 1994
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Levodopa‐induced diphasic dyskinesias improved by subcutaneous apomorphineMovement Disorders, 1992
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Selegiline in the treatment of Parkinson's disease - long term experienceActa Neurologica Scandinavica, 1989
- Effects of etybenzatropine and diazepam on levodopa‐induced diphasic dyskinesias in Parkinson's diseaseMovement Disorders, 1989
- Dystonia in parkinson's disease: Clinical and pharmacological featuresAnnals of Neurology, 1988